A new hope for pulmonary hypoplasia: amniotic fluid stem cell extracellular vesicles?
Ishara Atukorala , Lisa Hui
Extracellular Vesicles and Circulating Nucleic Acids ›› 2025, Vol. 6 ›› Issue (3) : 350 -4.
A new hope for pulmonary hypoplasia: amniotic fluid stem cell extracellular vesicles?
In a recent study, Antounians and colleagues (2024) investigated the potential of amniotic fluid stem cell-derived extracellular vesicles (AFSC-EVs) as a therapeutic intervention for pulmonary hypoplasia resulting from congenital diaphragmatic hernia (CDH). They demonstrated the pronounced inflammatory signature of the fetal hypoplastic lungs, marked by heightened macrophage density in a CDH rat model. Intra-amniotic AFSC-EV administration mitigated the inflammatory process and enhanced fetal lung development by promoting branching morphogenesis and epithelial maturation. These findings add to a growing body of preclinical and clinical evidence supporting the therapeutic potential of AFSC-EVs for inflammation-driven pathologies.
Extracellular vesicles / pulmonary hypoplasia / inflammation / amniotic fluid stem cells
| [1] |
|
| [2] |
|
| [3] |
Deprest JA, Nicolaides KH, Benachi A, et al; TOTAL Trial for Severe Hypoplasia Investigators. Randomized trial of fetal surgery for severe left diaphragmatic hernia. N Engl J Med. 2021;385:107-18. |
| [4] |
|
| [5] |
|
| [6] |
|
| [7] |
|
| [8] |
|
| [9] |
|
| [10] |
|
| [11] |
|
| [12] |
|
| [13] |
|
| [14] |
|
| [15] |
|
| [16] |
|
| [17] |
|
| [18] |
|
| [19] |
|
| [20] |
|
| [21] |
|
| [22] |
|
| [23] |
|
| [24] |
|
| [25] |
|
| [26] |
|
| [27] |
|
/
| 〈 |
|
〉 |